Contact

Dr. Solveig Pospiech

Head Thermo­dynamics of Actinides
s.pospiechAthzdr.de
Phone: +49 351 260 2430

Actinide thermodynamics department

Research

The department of “Thermodynamics of Actinides” is hosting a significant part of the analytical backbone of the institutes, e.g. mass spectrometry, atomic emission spectrometry, elemental analyses, powder diffraction, vibrational and nuclear magnetic resonance spectroscopy. This allows us to work on several steps in the thermodynamics value chain.

From a chemical point of view, the focus is set on heavy metal contaminants, namely long-lived radionuclides. The derivation of parameters describing hydrolysis, aqueous complexation, surface reactions or solubilities are combined with structural investigations to validate the species set forming reactions, enabling mechanistic models. Such parameters are fed into respective databases after verification. Gaps still remaining can be closed by applying different estimation methods, from mineral analogies to Linear Free Energy Relationships.

Combined with field data (mineralogical composition, porosity, pH, redox potential, ionic strength, temperature, or CO2 partial pressure), geochemical speciation patterns and radionuclide retardation can then be computed for complex systems on different scales. To name just a few, we worked on cementitious barriers with organic additives, with real-world crystalline samples or with Chornobyl soils. There, also, geostatistics helps to map the heterogeneities observed, and sensitivity / uncertainty analysis not only increases confidence in computational results but supports also the identification of critical parameters and submodels.

Quite recently, these approaches were complemented by machine learning methods, this will eventually lead to digital twins for nuclear waste repositories. Eventually, this shall bridge the distance between atomistic investigations and the large-scale prognostics required e.g. in performance assessment covering distances of several km over up to one million years.

The actual major research topics of our department can be summarized as follows:


Loading...

Latest publication

The second nitrogen fits: Development of diazine-based macrocy-clic chelators to stably bind radionuclides used in targeted alpha therapy

Blei, M. K.; Waurick, L.; Drobot, B.; Brühlmann, S. A.; Duchemin, C.; Mamis, E.; Inzamam, M.; Stora, T.; Audouin, N.; Sounalet, T.; Kopka, K.; Stumpf, T.; Stadlbauer, S.; Kretzschmar, J.; Mamat, C.

Abstract

Identifying suitable chelators for 212Pb, 223Ra, and 225Ac and their diagnostic counterparts 131Ba, 133La, and 203Pb remains one of the major challenges in the development of radiopharmaceuticals for targeted alpha therapy. Four novel macrocyclic chelators containing the 2,4- and 2,6-pyrimidine moiety (pym 2,4 and pym 2,6), along with a combination thereof (pym-mix), as well as the pyrazine moiety (pazi), were synthesized and fully characterized. Protonation constants (pKa) were de-termined using 1H NMR spectroscopy. Stability constants (log K) for the complexes with La3+ (11.8–12.6), Ba2+ (10.1–10.3), and Pb2+ (15.3–15.5) are lower compared to macropa. However, pH-dependent binding affinities (pKd,M) with the novel chelators are higher for Ba2+ (8.7–8.9) and comparable or slightly lower for La3+ and Pb2+ at pH 6. DFT calculations enabled comprehensive elucidation of the molecular structures, facilitating in-depth analyses of the coordination environment. The determined 15N NMR chemical shifts of free chelators and complexes help to explain distinct complexation behavior. Final-ly, the novel chelators were radiolabeled with 131Ba, 223Ra, 133La, 225Ac, 203Pb, and 212Pb, and the radiochemical conversions were compared to results with macropa. All 223Ra-complexes were incubated in human serum, pointing out an increased kinetic inertness and stability.

Keywords: barium-131; radium; targeted alpha therapy; actinium-225; macropa

Permalink: https://www.hzdr.de/publications/Publ-42963


More publications


Team


Head

NameBld./Office+49 351 260Email
Dr. Solveig Pospiech801/P2502430
s.pospiechAthzdr.de

Employees

NameBld./Office+49 351 260Email
Dr. Frank Bok801/P2023551
f.bok@hzdr.de
Prof. Dr. Vinzenz Brendler801/P2502430
v.brendler@hzdr.de
Rodrigo Castro Biondor.castro-biondoAthzdr.de
Alexandra Duckstein801/P1532774
a.ducksteinAthzdr.de
Dr. Jerome Kretzschmar801/P2073136
j.kretzschmarAthzdr.de
Dr. Elmar Plischkee.plischkeAthzdr.de
Dr. Anke Richter801/P2022426
anke.richterAthzdr.de
Raj Sarkar801/P1032720
r.sarkarAthzdr.de
Dr. Katja Schmeide801/P2082436
2513
k.schmeideAthzdr.de
Salim Shams Aldin Azzam801/P1032720
s.shamsAthzdr.de
Claudia Sieberc.sieberAthzdr.de
Susanne Zechel801/P3523328
s.zechelAthzdr.de

Other employees

NameBld./Office+49 351 260Email
Liya TomyF100/4314438
l.tomyAthzdr.de

Analytics

Head

NameBld./Office+49 351 260Email
Dr. Harald Foerstendorf801/P2513664
2504
h.foerstendorfAthzdr.de

Employees

NameBld./Office+49 351 260Email
Nick Augustinn.augustinAthzdr.de
Sabrina Beutner801/P2032429
2528
s.beutnerAthzdr.de
Tim Gitzel801/P3162025
2517
t.gitzelAthzdr.de
Dominik Goldbach801/P2033198
d.goldbachAthzdr.de
Karsten Heim801/P2012434
2504
k.heimAthzdr.de
Sylvia Schöne850/102.12526
3198
s.schoene@hzdr.de, s.schoeneAthzdr.de